Myoma arising in a Cervical Stump

Article

After having been almost abandoned, supracervical hysterectomy has been recently re-advocated, especially after the development of laparoscopy, because it is stated to have less morbidity and minor intra-operative complications. However, long term outcomes report high incidences of late complications

Introduction

After having been almost abandoned, supracervical hysterectomy has been recently re-advocated, especially after the development of laparoscopy, because it is stated to have less morbidity and minor intra-operative complications. However, long term outcomes report high incidences of late complications

Case Report

A 49 year-old patient  with a history of previous laparotomic myomectomy and one caesarean section, performed 12 years before, followed by supracervical hysterectomy for uterine rupture, referred to our practice complaining about urinary symptoms and  mild abdominal pain. A myoma arising in the cervical stump measuring 8 cm in width was diagnosed both by the pelvic examination and vaginal ultrasound. The myoma appeared to be fixed in the pelvic cavity, with absence of lateral movements. Cervical biopsies and cytology were benign. After 1 year, the myoma had increased of about 3 centimetres and a laparoscopy was planned.

Intervention

 

To allow a better mobilization of the myoma, the left uterine artery was identified and coagulated. The enucleation of the myoma was therefore easily carried out.

Video 3

 

'

The right uterine artery was coagulated and the trachelectomy completed by vaginal way.

Video 4

 


 

Discussion

 

A conflict arises in regard to preservation of the uterine cervix during hysterectomy. Alternative procedures, such as supracervical laparoscopic hysterectomy or classic intrafascial supra-cervical hysterectomy, have been recently proposed. Patients undergoing laparoscopic supracervical hysterectomy have been reported to have shorter operating times, shorter hospital stays, and less morbidity than those who underwent other types of hysterectomy . A less morbid approach can be advocated, in appropriate candidates, particularly if the procedure is readily accomplished by an increased number of physicians. Furthermore, some have argued that supracervical hysterectomy better preserves bladder and sexual function. However, for routine cases, the available literature does not confirm that one procedure is superior, regardless of the route of access.

 

The main disadvantage of subtotal hysterectomy over total one is the fact, that in 1 per 1000 women develops carcinoma in cervical stump.

 

The practice of routine preservation of the cervix at laparoscopic hysterectomy should be reconsidered. In fact, symptoms related to the cervical stump requiring further surgery frequently occur following a laparoscopic supracervical hysterectomy. Twenty-five percent of the patients continued to menstruate, and 10% had symptoms of discharge. Careful long-term analysis of results demonstrates a high complication rate reporting symptoms related to the cervical stump in 24% of patients, all requiring further operations. Adhesions, especially between the bowel and the cervical stump, endometriotic  lesions, cervical pathologies (chronic cervicitis, SIL, mucocoeles), myomas and prolapse have been reported at long-term follow-ups.

 

Nevertheless, it has to be stressed that cervical stump removal can be accomplished laparoscopically by an experienced surgeon.

 

Conclusion

Although preservation of the cervix with laparoscopic hysterectomy for benign diseases was satisfactory in most of the cases, several women had complications of the remaining cervix. Special attention should be paid to the careful treatment of the cervical stump. Further prospective studies are needed to evaluate the advantages of retaining the cervix at laparoscopic hysterectomy.

 

 

 

 

References:

Reprinted with kind permission from TheTrocar.com

References

Adamian LV, Kulakov VI, Dzhabrailova SSh. Characteristics of surgical treatment of pathologic conditions of the cervical stump. Akush Ginekol 1991; 5: 60-62. (Medline)

Bojahr B, Lober R, Romer T, Schwesinger G. Large cervix myoma after supra-cervical hysterectomy. Zentralbl Gynakol 1996; 118: 468-470. (Medline)

Lyons TL. Laparoscopic supracervical hysterectomy. A comparison of morbidity and mortality results with laparoscopically assisted vaginal hysterectomy. J Reprod Med 1993; 38: 763-767. (Medline)

Markowska J, Markowska A. Total or subtotal hysterectomy? Ginekol Pol 2000; 71: 34-38. (Medline)

Milad MP, Morrison K, Sokol A, et al. A comparison of laparoscopic supracervical hysterectomy vs laparoscopically assisted vaginal hysterectomy. Surg Endosc 2001; 15: 286-288. (Medline)

Munro MG. Supracervical hysterectomy: ... a time for reappraisal. Obstet Gynecol 199; 89:133-139. Review. (Medline)

Nezhat CH, Nezhat F, Roemisch M, et al. Laparoscopic trachelectomy for persistent pelvic pain and endometriosis after supracervical hysterectomy. Fertil Steril 1996; 66: 925-928. (Medline)

Okaro EO, Jones KD, Sutton C. Long term outcome following laparoscopic supracervical hysterectomy. BJOG 2001; 108: 1017-1020. (Medline)

Pelosi MA 3rd, Pelosi MA, Rudelli RD. Symptomatic cervical macrocyst as a late complication of subtotal hysterectomy. A case report. J Reprod Med 1999; 44: 567-570. (Medline)

van der Stege JG, van Beek JJ. Problems related to the cervical stump at follow-up in laparoscopic supracervical hysterectomy. JSLS 1999; 3:5-7. (Medline)

Wattiez A, Cohen SB, Selvaggi L. Laparoscopic hysterectomy. Curr Opin Obstet Gynecol 2002; 14: 417-422. (Medline)

Related Videos
Deciding the best treatment for uterine fibroids | Image Credit: jeffersonhealth.org.
What's new in endometrium care? | Image Credit: nyulangone.org
New algorithm to identify benign lesions developed | Image Credit: nemours.mediaroom.com
Discussing PCOS: misconceptions, management, encouragement | Image Credit: ahn.org
Anne Banfield, MD | Image Credit: © Medstar
Honoring Endometriosis Awareness Month | Image Credit: © Katsiaryna Hatsak - © Katsiaryna Hatsak - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.